DNA encapsulated magnesium and manganous phosphate nanoparticles: potential non-viral vectors for gene delivery.

Nanoparticles of Mg and Mn (II) phosphates encapsulating pDNA were prepared. The sizes of these DNA loaded particles in aqueous dispersion were about 100-130 nm diameter, and they aggregated with the progression of time. Although magnesium phosphate nanoparticles were crystalline, the manganous phosphate nanoparticles were found to be amorphous in nature. Nanoparticle dissolution and pDNA release were studied using atomic absorption spectroscopy and gel electrophoresis experiments. These inorganic phosphate nanoparticles dissolved in mild acidic pH ( approximately 5) releasing pDNA indicating that DNA release in the endosomal compartment is possible. In vitro transfection in HeLa cells demonstrated that while magnesium phosphate nanoparticles showed 100% efficiency, manganous phosphate nanoparticles exhibited about 85% transfection efficiency compared to that of 'polyfect', as control.

[1]  P. Hwu.  Gene therapy: progress and prospects. , 1994, Contemporary urology.

[2]  G. Farrar,et al.  Formulation of poly(D,L-lactic-co-glycolic acid) microparticles for rapid plasmid DNA delivery. , 2000, Journal of controlled release : official journal of the Controlled Release Society.

[3]  K. Leong,et al.  DNA-polycation nanospheres as non-viral gene delivery vehicles. , 1998, Journal of controlled release : official journal of the Controlled Release Society.

[4]  A. Maitra,et al.  pDNA loaded calcium phosphate nanoparticles: highly efficient non-viral vector for gene delivery. , 2005, International journal of pharmaceutics.

[5]  W. Mark Saltzman,et al.  Enhancement of transfection by physical concentration of DNA at the cell surface , 2000, Nature Biotechnology.

[6]  T. Schiestel,et al.  A nonviral DNA delivery system based on surface modified silica-nanoparticles can efficiently transfect cells in vitro. , 2000, Bioconjugate chemistry.

[7]  M. Beer,et al.  A DNA vaccine containing an infectious Marek's disease virus genome can confer protection against tumorigenic Marek's disease in chickens. , 2002, The Journal of general virology.

[8]  Gong Chen,et al.  Formation of an Endophilin-Ca2+ Channel Complex Is Critical for Clathrin-Mediated Synaptic Vesicle Endocytosis , 2003, Cell.

[9]  E Marshall,et al.  Gene Therapy Death Prompts Review of Adenovirus Vector , 1999, Science.

[10]  M. Ogris,et al.  Tumor-Targeted Gene Transfer with DNA Polyplexes , 2002, Somatic cell and molecular genetics.

[11]  R. Levy,et al.  Enhanced plasmid DNA transfection with lysosomotropic agents in cultured fibroblasts. , 2001, International journal of pharmaceutics.

[12]  P. Schlag,et al.  Efficient gene transfer into human hepatocytes by baculovirus vectors. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[13]  T. Niidome,et al.  Gene Therapy Progress and Prospects: Nonviral vectors , 2002, Gene Therapy.

[14]  D. Lauffenburger,et al.  Receptor‐mediated targeting of gene delivery vectors: Insights from molecular mechanisms for improved vehicle design , 2000, Biotechnology and bioengineering.

[15]  M. Ogris,et al.  Polylysine-based transfection systems utilizing receptor-mediated delivery. , 1998, Advanced drug delivery reviews.

[16]  F. Szoka,et al.  In vitro gene delivery by degraded polyamidoamine dendrimers. , 1996, Bioconjugate chemistry.

[17]  A. Maitra,et al.  Nanometer Silica Particles Encapsulating Active Compounds: A Novel Ceramic Drug Carrier , 1998 .

[18]  H. Merkle,et al.  Microencapsulation of DNA using poly(DL-lactide-co-glycolide): stability issues and release characteristics. , 1999, Journal of controlled release : official journal of the Controlled Release Society.

[19]  Mitsuru Hashida,et al.  Nonviral approaches satisfying various requirements for effective in vivo gene therapy. , 2002, Biological & pharmaceutical bulletin.

[20]  D. Stuckey,et al.  Bioconversion of hydrophobic compounds in a continuous closed-gas-loop bioreactor: feasibility assessment and epoxide production. , 2000, Biotechnology and bioengineering.

[21]  M. Neutra,et al.  Peptomer aluminum oxide nanoparticle conjugates as systemic and mucosal vaccine candidates: synthesis and characterization of a conjugate derived from the C4 domain of HIV-1MN gp120. , 1997, Bioconjugate chemistry.

[22]  J. Sambrook,et al.  Molecular Cloning: A Laboratory Manual , 2001 .

[23]  David Avnir,et al.  Enzymes and Other Proteins Entrapped in Sol-Gel Materials , 1994 .

[24]  M. Raffeld,et al.  Helper virus induced T cell lymphoma in nonhuman primates after retroviral mediated gene transfer , 1992, The Journal of experimental medicine.

[25]  C. Coutelle,et al.  Calcium ions as efficient cofactor of polycation-mediated gene transfer. , 1999, Biochimica et biophysica acta.